Mitochondrial

SS-31

Mitochondrial Peptide

Also referred to as elamipretide, MTP-131, Bendavia.

SS-31 is a synthetic tetrapeptide, also known by its clinical name elamipretide, designed to selectively accumulate in the inner mitochondrial membrane and stabilise cardiolipin — a phospholipid critical to mitochondrial architecture and energy production. Its alternating aromatic and positively charged amino acid residues allow it to cross biological barriers including the blood-brain barrier.

Research spans both preclinical animal models and registered human clinical trials, with studies published under both names (SS-31 and elamipretide).

Published on SS-31

Research OverviewSS-31 Peptide Combinations: What the Research Says About StackingSS-31 peptide is a mitochondria-targeting tetrapeptide, also known by its clinical alias elamipretide and by the research name Bendavia.
Research OverviewSS-31 Peptide: Research Outcomes and What Studies ReportSS-31 is a synthetic mitochondria-targeting tetrapeptide, also known by its clinical alias elamipretide and the earlier research name Bendavia, designed to concentrate at the inner mitochondrial membrane and stabilize cardiolipin — a phospholipid critical to mitochondrial energy production.
Research OverviewSS-31 Peptide: Safety Profile, Side Effects, and Risks in the ResearchSS-31 is a synthetic mitochondria-targeting tetrapeptide, also known by its clinical name elamipretide and its early research alias Bendavia.
Research OverviewSS-31 Peptide: Mechanism of Action, Research Overview, and Study FindingsSS-31 is a synthetic, mitochondria-targeted tetrapeptide, also known by its clinical development name elamipretide, designed to concentrate in the inner mitochondrial membrane and stabilize cardiolipin — a phospholipid critical to mitochondrial energy production.